Ibnsina Pharma Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Mohamed Mohsen Mahgoub

Chief executive officer


Total compensation

CEO salary percentagen/a
CEO tenure3.2yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure6.7yrs

Recent management updates

Recent updates


Mohamed Mohsen Mahgoub



Mr. Mohamed Mohsen Mohamed Mahgoub serves as Vice Chairman and Chief Executive Officer at Ibn Sina Pharma (S.A.E) since April 2021. He served as Executive Chairman until April 2021 and has been Director at...

Board Members

Mohamed Mohsen Mahgoub
Vice Chairman & CEO6.7yrsno datano data
Mahmoud Abdel-Gawad
Co-CEO & Director6.7yrsno data4.81%
EGP 132.0m
Omar Abdel-Gawad
Co-CEO & Director6.7yrsno data5.56%
EGP 152.4m
Mohamed Mohsen Mahgoub
Director6.7yrsno data8.12%
EGP 222.6m
Hany Hassanein Bader
Director6.7yrsno datano data
Abdel Fahmy
Director6.7yrsno datano data
Mohamed Abbas Mohamed Zaki
Director6.7yrsno data4.49%
EGP 123.2m
Abdel Aziz Abdel Aziz
Non-Executive Chairman6.7yrsno data0.15%
EGP 4.1m
Ahmed Abdelgawad Mahmoud
Directorno datano data4.61%
EGP 126.4m
Ahmed Al Nawawi
Directorno datano datano data


Average Tenure

Experienced Board: ISPH's board of directors are considered experienced (6.7 years average tenure).

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.